| Phytochemical Name | Carnosic acid |
| PubChem CID | 65126 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-PD-1 antibody; Cisplatin; Tamoxifen |
| Source |
Warm
Salvia rosmarinus
Cool
Verbena officinalis;
Cold
Artemisia scoparia;
|
| Phytochemical Name | Rosmarinic acid |
| PubChem CID | 5281792 |
| Disease Indication | Osteoarthritis of the knee [ICD-11: FA01] Phase 4 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-MUC1 antibody; Cisplatin; Indoleamine 2,3-dioxygenase 1; Inhibit UGT1A1-mediated bilirubin glucuronidation; Paclitaxel |
| Source |
Warm
Salvia rosmarinus
|
| Phytochemical Name | Carnosic acid |
| PubChem CID | 65126 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-PD-1 antibody; Cisplatin; Tamoxifen |
| Source |
Warm
Salvia rosmarinus
Cool
Verbena officinalis;
Cold
Artemisia scoparia;
|
| Phytochemical Name | Rosmarinic acid |
| PubChem CID | 5281792 |
| Disease Indication | Osteoarthritis of the knee [ICD-11: FA01] Phase 4 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Anti-MUC1 antibody; Cisplatin; Indoleamine 2,3-dioxygenase 1; Inhibit UGT1A1-mediated bilirubin glucuronidation; Paclitaxel |
| Source |
Warm
Salvia rosmarinus
|
